Optimal platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention

Resuscitation. 2018 Sep:130:e1-e2. doi: 10.1016/j.resuscitation.2018.06.032. Epub 2018 Jun 30.

Authors

Mathieu Fiore¹, Edouard Gerbaud², Pierre Coste², Laura Cetran², Hugo Marchand², Benjamin Seguy²

Affiliations

¹ Laboratory of Hematology, Reference Center for Platelet Disorders, University Hospital of Bordeaux, Pessac, France. Electronic address: mathieu.fiore@chu-bordeaux.fr.
² Cardiovascular Intensive Care Unit, Cardiologic Hospital, University Hospital of Bordeaux, Pessac, France.

PMID: 29969644
DOI: 10.1016/j.resuscitation.2018.06.032

No abstract available

Publication types

Letter

MeSH terms

Adenosine Monophosphate / administration & dosage
Adenosine Monophosphate / analogs & derivatives*
Adenosine Monophosphate / pharmacokinetics
Biological Availability
Coma* / etiology
Coma* / therapy
Female
Humans
Male
Middle Aged
Out-of-Hospital Cardiac Arrest / complications*
Out-of-Hospital Cardiac Arrest / therapy
Percutaneous Coronary Intervention / methods*
Platelet Function Tests / methods
Purinergic P2Y Receptor Antagonists / administration & dosage
Purinergic P2Y Receptor Antagonists / pharmacokinetics
Ticagrelor* / administration & dosage
Ticagrelor* / pharmacokinetics
Treatment Outcome

Substances

Purinergic P2Y Receptor Antagonists
Adenosine Monophosphate
cangrelor
Ticagrelor